Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

16.78
Delayed Data
As of 4:00pm ET
 +0.18 / +1.08%
Today’s Change
8.18
Today|||52-Week Range
17.55
+69.84%
Year-to-Date
Can Halozyme (HALO) Run Higher on Strong Earnings Estimate Revisions?
9:07am / Zacks.com - Paid Partner Content
Good Stocks Are There for the Picking
Sep 15 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised ...
Sep 20 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Collaborates With Halozyme for ENHANZE
Sep 15 / Zacks.com - Paid Partner Content
Strong Action in Individual Stocks Starts to Feel a Bit Frothy
Sep 18 / TheStreet.com - Paid Partner Content
Strength Seen in Halozyme Therapeutics (HALO): Stock Soars 21.2%
Sep 15 / Zacks.com - Paid Partner Content